Moratorium urged on bisphenol A in baby bottles, food and beverage containers
Groups call for moratorium on Bisphenol A in baby bottles, food, beverage containers
PhRMA supports National Drug Prevention and Education week
PhRMA applauds resolution creating National Drug Prevention and Education Week
Study: Primary healthcare distributors save healthcare system billions
Drug distributors save healthcare system nearly $34 billion a year
Two conmen sentenced for defrauding Medicaid
Washington authorities sentence two individuals who helped a pharmacy defraud Medicaid
Aetna takes heat over its policy on propofol for colonoscopy
Aetna insists the average colonoscopy patient does not need the presence of an anesthesiologist to administer propofol.
FDA lights more fire under smoking-cessation drug Chantix
FDA issues public health advisory on varenicline
Asmanex now OK for younger children with asthma
Mometasone powder approved for younger children
FDA: Several SynchroMed EL Implantable Infusion Pump models recalled
FDA recalls several SynchroMed EL Implantable Infusion Pump models
NCPA supports White House's task force to end teenage prescription drug abuse
NCPA applauds White House's creation of task force to end teenage prescription drug abuse
AAHomecare: Seniors' access to DME would be impacted by President's budget
AAHomecare: President's proposed budget would weaken seniors' access to DME
Free OTC smoking cessation products available from GSK
GSK offering free OTC smoking cessation products to help consumers stop smoking
Survey shows doctors are opposed to Medicare ESA decision
Many physicians reported in a survey that a Medicare decision on erythropoiesis stimulating agents has hurt their patients.
Most R.Ph.s don't think PBMs have a stranglehold over specialty pharmacy
An online Drug Topics poll finds that community pharmacists think there's still room for them to get into specialty pharmacy.
Study: Vitamin and mineral use among cancer survivors is widespread
Study finds widespread vitamin and mineral use among cancer survivors
New label approved to reflect Thrombin-JMI manufacturing changes
FDA approves revised labeling for Thrombin-JMI.
NACDS breaks ad campaign highlighting role of pharmacy
NACDS launches advertising campaign touting pharmacy.
NCPDP to doctors: Get ready for tamper-resistant Rx pads
The National Council for Prescription Drug Programs urges physicians to get going on ordering tamper-resistant Rx pads.
Medtronic gets nod for its drug-eluting stent
FDA approves zotarolimus drug-eluting stent
Reducing your risk: Medication errors - A plan for quality
Create a plan to standardize your process and and training to help prevent mistakes.
Can you explain pharmacy to an eighth grader?
Pharmacists should spread the word that they are the medication experts.
Consumers Union to FDA: Make it easier for patients to report Rx side effects
Consumers Union petitions FDA to make it easier for patients to report side effects from prescription drugs
Eye drops and eye/ear wash products recalled by FDA, NuCel Labs
FDA, NuCel Labs recalls eye drops and eye/ear wash products
Study: Folic acid one year before conception results in huge drop in preterm birth risk
Researchers report a huge drop in preterm birth risk among women taking folic acid one year before conception
Part D grows, but remains under budget
Medicare Part D grows by 1.5 million beneficiaries while remaining under budget.
FDA: Antiepileptics are linked to increased risk of suicide
FDA finds increased risk of suicide in patients taking seizure drugs
Teamsters stage one-day strike at wholesaler's Wash. facility
Teamsters went on strike for one day at an AmerisourceBergen distribution center.
Pharmacy owner in steroid probe kills self
A pharmacist accused of selling steroids to athlete committed suicide in New York.
Many schizophrenic patients stop taking drugs due to side effects
Survey finds a low drug compliance rate among schizophrenic patients
Merck gets approval for intravenous antiemetic
Merck extends its Emend line with a new intravenous form
Insomnia drug should be classified under Schedule IV, DEA says
Drug Enforcement Administration proposes placing indiplon in Schedule IV
